Owens David
SEC insider (Form 3/4/5 filer). CIK 0001916664. Chief Medical Officer at Nexalin Technology, Inc. (NXL). 15 reported Form 4/5 transactions since Sep 2024; latest on Dec 19, 2025. Located in ATLANTA, GA.
Companies Owens David has filed insider reports for
- Nexalin Technology, Inc. (NXL): Director, Officer, Chief Medical Officer
Owens David
CIK: 0001916664
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nexalin Technology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Dec 19, 2025NXL
Nexalin Technology, Inc.
AwardDirectStock Option (right to buy)*
1M shares- - Sep 29, 2025NXL
Nexalin Technology, Inc.
AwardDirect36.5K shares- - Sep 12, 2025NXL
Nexalin Technology, Inc.
AwardDirectStock Option (right to buy)
203.1K shares- - Sep 12, 2025NXL
Nexalin Technology, Inc.
AwardDirectStock Option (right to buy)
100K shares- - Feb 26, 2025NXL
Nexalin Technology, Inc.
AwardDirectStock Option (right to buy)
654.4K shares- - Feb 26, 2025NXL
Nexalin Technology, Inc.
AwardDirectStock Option (right to buy)
125K shares- - Feb 26, 2025NXL
Nexalin Technology, Inc.
AwardDirectStock Option (right to buy)
139.8K shares- - Feb 4, 2025NXL
Nexalin Technology, Inc.
PurchaseDirect1K shares at avg. $3.10$3K - Feb 4, 2025NXL
Nexalin Technology, Inc.
PurchaseDirect1K shares at avg. $2.98$3K - Jan 28, 2025NXL
Nexalin Technology, Inc.
PurchaseDirect1.5K shares at avg. $2.70$4K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 19, 2025 | NXL Nexalin Technology, Inc. | Award Stock Option (right to buy)* | 1,000,000 | - | - | Direct |
| Sep 29, 2025 | NXL Nexalin Technology, Inc. | Award | 36,459 | - | - | Direct |
| Sep 12, 2025 | NXL Nexalin Technology, Inc. | Award Stock Option (right to buy) | 203,125 | - | - | Direct |
| Sep 12, 2025 | NXL Nexalin Technology, Inc. | Award Stock Option (right to buy) | 100,000 | - | - | Direct |
| Feb 26, 2025 | NXL Nexalin Technology, Inc. | Award Stock Option (right to buy) | 654,363 | - | - | Direct |
| Feb 26, 2025 | NXL Nexalin Technology, Inc. | Award Stock Option (right to buy) | 125,000 | - | - | Direct |
| Feb 26, 2025 | NXL Nexalin Technology, Inc. | Award Stock Option (right to buy) | 139,821 | - | - | Direct |
| Feb 4, 2025 | NXL Nexalin Technology, Inc. | Purchase | 1,000 | $3.10 | $3,100 | Direct |
| Feb 4, 2025 | NXL Nexalin Technology, Inc. | Purchase | 1,000 | $2.98 | $2,980 | Direct |
| Jan 28, 2025 | NXL Nexalin Technology, Inc. | Purchase | 1,500 | $2.70 | $4,050 | Direct |
1-10 of 15 transactions